Multiple roles of the PGE2-EP receptor signal in vascular permeability

British Journal of Pharmacology

Volumn 171, Issue 21, 2014, Pages 4879-4889

  Omori, K ^a   Kida, T ^a   Hori, M ^a   Ozaki, H ^a   Murata, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEXTRAN; PHENYLEPHRINE; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; THROMBIN; PROSTAGLANDIN E2; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD VESSEL DIAMETER; BLOOD VESSEL PARAMETERS; BLOOD VESSEL PERMEABILITY; CELL ISOLATION; COLOR ULTRASOUND FLOWMETRY; DRUG EFFECT; ELECTRIC RESISTANCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROSCOPY; MOUSE; NONHUMAN; PERICYTE; SIGNAL TRANSDUCTION; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASODILATATION; AGONISTS; ANIMAL; CAPILLARY PERMEABILITY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SKIN;

ANIMALS; CAPILLARY PERMEABILITY; CYCLIC AMP; DINOPROSTONE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATION;

EID: 84918821351     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12815     Document Type: Article

References (38)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol. 170: 1459-1581.
2. Armstead WM (1995). Role of nitric oxide and cAMP in prostaglandin-induced pial arterial vasodilation. Am J Physiol 268 (4 Pt 2): H1436-H1440.
3. Armulik A, Genove G, Betsholtz C (2011). Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21: 193-215.
4. Bates DO (2010). Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87: 262-271.
5. Birukova AA, Zagranichnaya T, Fu P, Alekseeva E, Chen W, Jacobson JR et al. (2007). Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA-and Epac1/Rap1-dependent Rac activation. Exp Cell Res 313: 2504-2520.
6. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH (2004). Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36: 1187-1205.
7. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001). Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-690.
8. Curry FR (2005). Microvascular solute and water transport. Microcirculation 12: 17-31.
9. Curry FR, Adamson RH (2010). Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiovasc Res 87: 218-229.
10. Dejana E, Orsenigo F, Lampugnani MG (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121 (Pt 13): 2115-2122.
11. Feletou M, Bonnardel E, Canet E (1996). Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide. Br J Pharmacol 118: 1371-1376.
12. Funk CD (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
13. Hahn C, Schwartz MA (2009). Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 10: 53-62.
14. Hatae N, Sugimoto Y, Ichikawa A (2002). Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem 131: 781-784.
15. Hirase T, Node K (2011). Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 302: H499-H505.
16. Kida T, Sawada K, Kobayashi K, Hori M, Ozaki H, Murata T (2014). Diverse effects of prostaglandin E2 on vascular contractility. Heart Vessels 29: 390-395.
17. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
18. Kobayashi K, Murata T, Hori M, Ozaki H (2011). Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery. Eur J Pharmacol 660: 375-380.
19. Kobayashi K, Tsubosaka Y, Hori M, Narumiya S, Ozaki H, Murata T (2013). Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway. Arterioscler Thromb Vasc Biol 33: 565-571.
20. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M et al. (1999). Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99: 301-312.
21. Levick JR, Michel CC (2010). Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 87: 198-210.
22. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
23. Majno G, Palade GE (1961). Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 11: 571-605.
24. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
25. Mehta D, Malik AB (2006). Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367.
26. Morales-Ruiz M, Lee MJ, Zollner S, Gratton JP, Scotland R, Shiojima I et al. (2001). Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276: 19672-19677.
27. Murata T, Lin MI, Aritake K, Matsumoto S, Narumiya S, Ozaki H et al. (2008). Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo. Proc Natl Acad Sci U S A 105: 20009-20014.
28. Nathan RA (2008). The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis. Clin Ther 30: 573-586.
29. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S et al. (2012). Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3: 1208.
30. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, Davenport AP, McGrath JC, Peters JA, Southan C, Spedding M, Yu W, Harmar AJ; NC-IUPHAR. (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-106.
31. Potter MD, Barbero S, Cheresh DA (2005). Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280: 31906-31912.
32. Szekanecz Z, Koch AE (2008). Vascular involvement in rheumatic diseases: 'vascular rheumatology. Arthritis Res Ther 10: 224.
33. Thibeault S, Rautureau Y, Oubaha M, Faubert D, Wilkes BC, Delisle C et al. (2010). S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell 39: 468-476.
34. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD et al. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514.
35. Wang Z, Ginnan R, Abdullaev IF, Trebak M, Vincent PA, Singer HA (2010). Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. J Biol Chem 285: 21303-21312.
36. Ware LB, Matthay MA (2000). The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349.
37. Weis SM (2008). Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 15: 243-249.
38. Zhou G, Kamenos G, Pendem S, Wilson JX, Wu F (2012). Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am J Physiol Regul Integr Comp Physiol 302: R409-R416.